Avanos Medical Acquired by AIP and Taken Private
TipRanks (Thu, 30-Jul 5:13 PM ET)
American Industrial Partners Completes Acquisition of Avanos Medical, Inc.
PRNewswire (Mon, 27-Jul 9:29 AM ET)
Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners
PRNewswire (Wed, 22-Jul 4:05 PM ET)
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
PRNewswire (Mon, 20-Jul 5:43 PM ET)
PRNewswire (Thu, 2-Jul 10:00 AM ET)
Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders?
PRNewswire (Thu, 25-Jun 1:59 PM ET)
Business Wire (Wed, 24-Jun 2:54 PM ET)
Globe Newswire (Tue, 23-Jun 9:20 PM ET)
Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?
PRNewswire (Fri, 12-Jun 11:47 AM ET)
Are CZR, AVNS, GBTG Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 1-Jun 3:26 PM ET)
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
Avanos Medical trades on the NYSE stock market under the symbol AVNS.
As of July 31, 2026, AVNS stock price was flat at $24.99 with million shares trading.
AVNS has a beta of 2.11, meaning it tends to be more sensitive to market movements. AVNS has a correlation of 0.17 to the broad based SPY ETF.
AVNS has a market cap of $1.17 billion. This is considered a Small Cap stock.
Last quarter Avanos Medical reported $182 million in Revenue and $.22 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.06.
In the last 3 years, AVNS traded as high as $25.49 and as low as $9.30.
The top ETF exchange traded funds that AVNS belongs to (by Net Assets): VTI, VXF, VTWO, VIOO, VHT.
AVNS has outperformed the market in the last year with a price return of +114.1% while the SPY ETF gained +18.9%. However, in the short term, AVNS had mixed performance relative to the market. It has underperformed in the last 3 months, returning +1.5% vs +4.2% return in SPY. But in the last 2 weeks, AVNS shares have fared better than the market returning +0.1% compared to SPY -0.5%.
AVNS support price is $24.93 and resistance is $25.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVNS shares will trade within this expected range on the day.
